Results 121 to 130 of about 34,423 (243)
Case Reports in Gastroenterology, 2017 Carbohydrate antigen 19-9 (CA19-9) is a well-known tumor marker for pancreatobiliary cancer, and several studies have shown that an elevated serum CA19-9 level is associated with more aggressive biological behavior in gastric cancer (GC).
Tan Wang +8 more
doaj +1 more source
Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary [PDF]
, 2014 Mature cystic teratoma is a common benign neoplasm of the ovary. Complications occur in approximately 20% of cases. Clinical manifestations, laboratory findings, and imaging studies can assist in making a diagnosis of ovarian torsion of mature cystic ...
김기형
core
Intradiaphragmatic mesothelial cyst with elevated CA19-9.
The Journal of the Japanese Association for Chest Surgery, 1995 横隔膜原発腫瘍は, まれな疾患である.我々は, CA19-9が嚢腫内容液, 末梢血液ともに高値を呈した横隔膜中皮嚢腫を経験したので報告する.症例は72歳男性で, 平成3年2月より右側腹部痛を訴えるようになった.CTにて右上腹部の cysticmass を認め経過観察していたが, 径の増大を認め精査入院となった.入院時現症, 末梢血液像, 一般生化学, 尿所見に異常はなかった.末梢血液中の腫瘍マーカ一はCA19-92.800 U/ml, SPAN-1645 U/ml, CA-50619 U/mlと 高値を呈した.腹部超音波像, CT像, MRI像にて, 右側前外側胸壁に接し, 横隔膜より尾側で胸腔外, 肝外に10×8cm大のcysticmassを認めた.腹腔鏡にて横隔膜由来の嚢腫と確診し ...
Tsutomu Tagawa +10 more
openaire +2 more sources
Cancer Medicine, Volume 15, Issue 5, May 2026.ABSTRACT Background Response to neoadjuvant chemoradiotherapy (NACRT) in locally advanced rectal cancer (LARC) is highly heterogeneous. Reliable pretreatment prediction of tumor regression and prognosis remains an unmet clinical need to optimize personalized management.
Xiaoli Jin +7 more
wiley +1 more source
Epidermoid Cyst of Spleen [PDF]
, 2010 Splenic cysts are very rare lesions, most of them being parasitic systs. Nonparasitic cysts are uncommon. We report a case of young female who presented with mass and pain abdomen. Ultrasound examination revealed splenic syst. The diagnosis of epidermoid
Usha, R, Vijay Shankar, S
core +1 more source
Cancer Medicine, Volume 15, Issue 5, May 2026.ABSTRACT Both fruquintinib and TAS‐102 monotherapies are guideline‐recommended for third‐line treatment of metastatic colorectal cancer (mCRC). This study aimed to analyze the preliminary outcomes of fruquintinib combined with TAS‐102, with or without stereotactic body radiation therapy (SBRT), as a third‐ or later‐line therapy for mCRC.
Yi Wang +19 more
wiley +1 more source
Prostate cancer with high serum level of CEA and CA19-9: a case report [PDF]
, 1998 症例は80歳男で, 食欲不振を主訴とする.入院時血清CEA, CA19-9, 血清PSAは高値を示していた.CTにて大動脈周囲のリンパ節腫脹を認め, 骨シンチでは多発性骨転移を認めた.前立腺針生検で悪性所見を認めなかった.前立腺癌が疑われ, 内分泌療法を開始したが, 2ヵ月後に死亡した.剖検試料は組織学的に前立腺癌(低分化型腺癌)であり, 肺, 肝, 甲状腺, 骨髄, 副腎に転移を認めたWe report a case of primary adenocarcinoma of the prostate ...
小野田, 登 +3 more
core
Cancer Medicine, Volume 15, Issue 5, May 2026.ABSTRACT Background Microsatellite stable/proficient mismatch repair (MSS/pMMR) colorectal cancer liver metastases (CRCLM) have limited treatment options after failure of second‐line systemic therapies. Hepatic artery infusion chemotherapy (HAIC) combined with targeted therapy and immunotherapy may offer improved outcomes.
Ran You +9 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 5, May 2026.ABSTRACT Background and Aims This study aimed to explore the predictive value of intratumoral proton density fat fraction (PDFF) and the clinical efficacy of hepatic arterial infusion chemotherapy (HAIC) combined with anti‐programmed cell death protein 1 (anti‐PD‐1) therapy in advanced hepatocellular carcinoma (HCC).
Yujie Ye +9 more
wiley +1 more source
, 1990 騨臓疾患は最も診断法の進歩が遅れていた領域であるが， 近年画像診断の進歩， 新しい腫傷マーカーの開発などにより， 陣臓癌の診断法は急速に進歩しつつある。特に近年， CA19-9 をはじめとする多数の腫虜マーカーが開発きれ， 臨床に応用されている。しかしながら， 現実には単独の腫蕩マーカーの診断能には明らかに限界がある。そこでカ一をコンビネ一シヨンで、m1J定することにより’ 診断能を向上させようという試みがなされて来た。しかし複数の項目を測定すれば， 感度（ sensitivity )は増加するが ...
斎藤 清二
core +1 more source